Pfizer slashed its full-year earnings and revenue guidance as it sees demand for its Covid treatment and vaccine wane. The company also launched a cost-cutting plan, which it expects to produce $1 ...
Pfizer posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched ...
Pfizer's financial results have been subpar in recent years. The company's newer products are starting to come into their own. The drugmaker's pipeline could lead to even more important brand-new ...
And while its revenue looked encouraging, rising 5% year over year, the company's net income fell 9%. And on an adjusted basis, its income was down even more -- by 18%. If a company's earnings ...
The 2026 R&D agenda includes approximately 20 planned pivotal study starts, 8 key data readouts, and 4 regulatory decisions. Pfizer intends to advance 10 Phase III studies in obesity this year, ...
The pharmaceutical powerhouse still faces plenty of patent challenges, but it got a big one out of the way, securing time and ...
Zacks Investment Research on MSN
Can Pfizer achieve high single-digit revenue CAGR from 2029?
On its first-quarter 2026 conference call held on May 5, Pfizer PFE CEO Albert Bourla said the company expects a high ...
In my March article, "Why Pfizer Remains A Strong Buy In 2026", I mainly discussed Pfizer's Q4 earnings ( PFE) and the ...
Pfizer (PFE) posted Q3 revenue of $16.65B down 5.9% as COVID products declined sharply. Paxlovid dropped 55% and Comirnaty fell 20%. Teva (TEVA) delivered its 11th consecutive quarter of growth with ...
Pfizer (NYSE:PFE) will release its quarterly earnings report on Tuesday, 2026-02-03. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Pfizer to report an earnings ...
Can Pfizer get back to growing its business? Ultimately, whether or not Pfizer's stock can go on a prolonged rally will depend on the outlook growth investors have for the business. At a time when the ...
Zacks Investment Research on MSN
Is trending stock Pfizer Inc. (PFE) a buy now?
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results